Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Leading Edge Innovations

Leading Edge Innovations?uq=hBqTzBbB
2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
PE Growth LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Formulator of skincare, cosmetic, personal care and OTC products, helping brands meet the needs of an ever-evolving beauty market. The company uses its proprietary technique MicroSperse to formulate product components for use in over-the-counter drugs and personal care products so that they mix without the use of chemical emulsifiers, many of which are on the Food and Drug Administration's "Watch List"

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Personal Products
Other Industries
Specialty Chemicals
Primary Office
  • 50 Tannery Road
  • Suite 5
  • Branchburg, NJ 08876
  • United States

+1 (908) 000-0000

Leading Edge Innovations Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Leading Edge Innovations‘s full profile, request access.

Request full access to PitchBook

Leading Edge Innovations Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Leading Edge Innovations‘s full profile, request access.

Request full access to PitchBook

Leading Edge Innovations Executive Team (1)

Name Title Board
Seat
Contact
Info
James Wilmott Founder, Owner, Chief Scientific Officer and Principal